Effect of complement activation with cobra venom factor on pulmonary vascular permeability
Authors:
- A. JohnsonAJA. Johnson
- J. A. CooperJCJ. A. Cooper
- A. B. MalikAMA. B. Malik
- 1 December 1986
- journal article
- research article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 61 (6) , 2202-2209
Abstract
We examined the effect of acute complement activation on lung vascular permeability to proteins in awake sheep prepared with lung lymph fistulas. Complement was activated by cobra venom factor (CVF) infusion (400 U/kg for 1 h iv). Studies were made in two groups of sheep: 1) infusion of CVF containing the endogenous phospholipase A2 (PLA2) (n = 6); and 2) infusion of CVF pretreated with bromophenacyl bromide to inhibit PLA2 activity (n = 5). Intravascular complement activation transiently increased mean pulmonary arterial pressure (.ovrhdot.Ppa) and pulmonary vascular resistance (PVR) in both groups. Pulmonary lymph flow (.ovrhdot.Qlym) and lymph protein clearance (.ovrhdot.Qlym .times. lymph-to-plasma protein concentration ratio) were also transiently increased in both groups. Pulmonary vascular permeability to proteins was assessed by raising left atrial pressure and determinining the lymph-to-plasma protein concentration ratio (L/P) at maximal .ovrhdot.Qlym. In both groups the L/P at maximal .ovrhdot.Qlym was not different from normal. In a separate group (n = 4), CVF-induced complement activation was associated with 111In-oxine granulocyte sequestration in the lungs. In vitro plasma from CVF-treated animals aggregated neutrophils but did not stimulate neutrophils to produce superoxide anion generation. Therefore, CVF-induced complement activation results in pulmonary neutrophil sequestration and in increases in PVR and lymph protein clearance. The increase in lymph protein clearance is due to increased pulmonary microvascular pressure and not increased vascular permeability to proteins.Keywords
This publication has 18 references indexed in Scilit:
- Effect of complement depletion on lung fluid balance after thrombinJournal of Applied Physiology, 1983
- Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites.Journal of Clinical Investigation, 1982
- ABSENCE OF INFLAMMATORY LUNG INJURY IN RABBITS CHALLENGED INTRA-VASCULARLY WITH COMPLEMENT-DERIVED CHEMOTACTIC FACTORS1982
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- PULMONARY INJURY INDUCED BY ANAPHYLATOXINS-C3A AND C5A-ANAPHYLATOXINS1980
- The Release of a Platelet-Activating Factor by Stimulated Rabbit NeutrophilsThe Journal of Immunology, 1979
- Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.Journal of Clinical Investigation, 1978
- PHOSPHOLIPASE-A-2 CONTAMINATION OF COBRA VENOM FACTOR PREPARATIONS - BIOLOGIC ROLE IN COMPLEMENT-DEPENDENT INVIVO REACTIONS AND INACTIVATION WITH PARA-BROMOPHENACYL BROMIDE1978
- Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.Journal of Clinical Investigation, 1977
- Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.Journal of Clinical Investigation, 1977